Bioanalytical Testing Services Market Segmentation:
The cardiology segment is estimated to attain the largest share of the bioanalytical testing services market over the forecast period. The growth of the segment can be accounted to the rising cases of cardiovascular diseases owing to unhealthy life choices, lack of exercise, and smoking habits. For instance, in 2020, approximately 600,000 people lost their lives in the United States as a result of cardiovascular disease.
The small molecules segment will dominate majority revenue share by 2035, owing to its crucial role in creating generic versions of branded medications, the small molecule testing services sub-segment is predicted to experience growth. The effectiveness of simulating generic medication release profiles with those of branded drugs has been demonstrated through bioanalytical testing, which has contributed to the segment's expansion.
Our in-depth analysis of the global bioanalytical testing services market includes the following segments:
|
By Type |
|
|
By Molecule Type |
|
|
By Application |
|
|
By End-User |
|
